Highlights Next Science Limited

Equities

NXS

AU0000041329

Delayed Australian S.E. Other stock markets 02:10:59 2024-05-14 am EDT			5-day change	1st Jan Change
0.38 ^AUD	0.00%		+5.56%	+11.76%

May. 03	Transcript : Next Science Limited - Shareholder/Analyst Call
Apr. 24	Next Science Product Sales Rise 19% to $5.5 Million for March Quarter	MT

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Study Showing Benefit from Next Science's XPERIENCE Now Published in Scientific Journal	Apr. 19	MT
Next Science's BLASTX Found to be Efficacious in Treating Pressure Ulcers With Therapy, Says Study	Apr. 09	MT
Next Science's Loss Widens in 2023 Despite 89% Revenue Growth; Shares Down 7%	Feb. 27	MT
Next Science Limited Provides Revenue Guidance for the Fiscal Year 2024	Feb. 27	CI
Next Science Limited Reports Earnings Results for the Full Year Ended December 31, 2023	Feb. 27	CI
Next Science Limited Reports Earnings Results for the Half Year Ended June 30, 2023	23-08-30	CI
Next Science Limited Announces Board Changes	23-08-22	CI
Next Science Limited Announces Retirement of Bruce Hancox as Non-Executive Director	23-06-29	CI
Next Science Limited Commercialising Its Proprietary Xbiotm Suite of Products	23-06-28	CI
Next Science Limited Reports Earnings Results for the Full Year Ended December 31, 2022	23-02-27	CI
Next Science's Collagen Products Secure Medicare Accreditation in the US; Shares Jump 8%	22-10-19	MT
Next Science Limited Announces the Launch of Topical Collagen Products	22-10-18	CI
Next Science Secures License for Wound Cleaning Product in Canada	22-08-26	MT
Next Science Limited Announces Health Canada Given Licensing Approval for XPERIENCE	22-08-25	CI
Next Science Limited Reports Earnings Results for the Half Year Ended June 30, 2022	22-08-24	CI
Next Science Secures Australia, New Zealand Distributor for Wound Dressing Product	22-05-19	MT
Next Science Limited Signed Multi-Year Distribution Agreement with Oraderm Pharmaceuticals	22-05-18	CI
Next Science Xperience(Tm) No Rinse Solution Shows Persistent Efficacy Against Both Planktonic Bacteria and Bacterial Biofilms	22-05-10	CI
Next Science Limited Reports Earnings Results for the Full Year Ended December 31, 2021	22-02-22	CI
Next Science Limited Signs Sales & Distribution Relationship Agreement with Zimmer, Inc	22-01-30	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Next Science Limited

Equities

NXS

AU0000041329

Highlights

Filters